Anson Funds Management LP Bausch Health Companies Inc. Transaction History

Anson Funds Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $706,000 - $2.36 Million	100,000 New	100,000 $836,000
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $1.5 Million - $1.8 Million	-60,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$27.43 - $32.7 $548,600 - $654,000	20,000 Added 50.0%	60,000 $1.76 Million
Q1 2021 May 14, 2021	BUY	$21.37 - $34.38 $854,800 - $1.38 Million	40,000 New	40,000 $1.27 Million
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $395,890 - $922,625	-30,500 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $576,145 - $972,645	30,500 New	30,500 $913,000
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $12.1 Million - $14.9 Million	-581,569 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $11.9 Million - $15.4 Million	581,569 New	581,569 $14.7 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

Stay updated on Anson Funds Management LP with notifications on news.